EUVIMEDEUVIMED entdecken
Open Access

Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes

Alessandra Giannella, Esmeralda Castelblanco, Carlo Federico Zambon, Daniela Basso, Marta Hernandez, Emilio Ortega, Nuria Alonso, Didac Mauricio iD, Angelo Avogaro iD, Giulio Ceolotto iD, Saula Vigili de Kreutzenberg

Diabetes Care · 2023

DOI: 10.2337/dc22-1441 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, 2023. Verfasst von Alessandra Giannella und 10 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Medicine, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Diabetes Mellitus, Type 1, RNA, Small Untranslated, MicroRNAs. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Università degli Studi di Padova.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Cardiovascular disease (CVD) accounts for most deaths in patients with type 1 diabetes (T1D); however, the determinants of plaque composition are unknown. miRNAs regulate gene expression, participate in the development of atherosclerosis, and represent promising CVD biomarkers. This study analyzed the circulating miRNA expression profile in T1D with either carotid calcified (CCP) or fibrous plaque (CFP). RESEARCH DESIGN AND METHODS Circulating small noncoding RNAs were sequenced and quantified using next-generation sequencing and bioinformatic analysis in an exploratory set of 26 subjects with T1D with CCP and in 25 with CFP. Then, in a validation set of 40 subjects with CCP, 40 with CFP, and 24 control subjects with T1D, selected miRNA expression was measured by digital droplet PCR. Putative gene targets enriched for pathways implicated in atherosclerosis/vascular calcification/diabetes were analyzed. The patients’ main clinical characteristics were also recorded. RESULTS miR-503-5p, let-7d-5p, miR-106b-3p, and miR-93-5p were significantly upregulated, while miR-10a-5p was downregulated in patients with CCP compared with CFP (all fold change >±1.5; P < 0.05). All candidate miRNAs showed a significant correlation with LDL-cholesterol, direct for the upregulated and inverse for the downregulated miRNA, in CCP. Many target genes of upregulated miRNAs in CCP participate in osteogenic differentiation, apoptosis, inflammation, cholesterol metabolism, and extracellular matrix organization. CONCLUSIONS These findings characterize miRNAs and their signature in the regulatory network of carotid plaque phenotype in T1D, providing new insights into plaque pathophysiology and possibly novel biomarkers of plaque composition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plaque, AtheroscleroticDiabetes Mellitus, Type 1RNA, Small UntranslatedMicroRNAsAtherosclerosisHumansOsteogenesisBiomarkersCholesterol

Substanzen

RNA, Small UntranslatedMicroRNAsBiomarkersCholesterol

Autor:innen und Institutionen

  • 1Department of Medicine, University of Padova, Padova, Italy.
  • 2Division of Endocrinology, Metabolism and Lipid Research, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO.
  • 3Unitat de Suport a la Recerca Barcelona, Institut Universitari d'Investigació en Atenció Primària Jordi Gol i Gurina, Barcelona, Spain.
  • 4Department of Endocrinology & Nutrition, Hospital Arnau de Vilanova and Institut d'Investigació Biomédica de Lleida, Lleida, Spain.
  • 5Department of Endocrinology & Nutrition, Diabetes Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
  • 6Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

ORCID-Profile: Didac Mauricio, Angelo Avogaro, Giulio Ceolotto

Förderung

  • Università degli Studi di Padova

Zitieren

APA

Giannella, A., Castelblanco, E., Zambon, C. F., Basso, D., Hernandez, M., Ortega, E., Alonso, N., Mauricio, D., Avogaro, A., Ceolotto, G., & Vigili de Kreutzenberg, S. (2023). Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes. Diabetes Care. https://doi.org/10.2337/dc22-1441

Vancouver

Giannella A, Castelblanco E, Zambon CF, Basso D, Hernandez M, Ortega E, et al. Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes. Diabetes Care. 2023. doi:10.2337/dc22-1441

BibTeX
@article{Giannella2023,
  author = {Giannella, Alessandra and Castelblanco, Esmeralda and Zambon, Carlo Federico and Basso, Daniela and Hernandez, Marta and Ortega, Emilio and Alonso, Nuria and Mauricio, Didac and Avogaro, Angelo and Ceolotto, Giulio and Vigili de Kreutzenberg, Saula},
  title = {Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes},
  journal = {Diabetes Care},
  year = {2023},
  doi = {10.2337/dc22-1441}
}
Kostenlos starten →